| Verizon Breaks Industry Mold to Put Customers First |
Globe Newswire |
06/16 |
07:00 |
| Dignitas Wins NAIC: The ROOT Brands Powers Pokémon UNITE Victory |
Globe Newswire |
06/15 |
17:53 |
| Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma |
Globe Newswire |
06/15 |
08:00 |
| Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma |
Globe Newswire |
06/14 |
03:15 |
| Rally House Ready with New York Knicks Championship Gear Following NBA Finals Victory |
Globe Newswire |
06/14 |
00:22 |
| As the 2026 World Cup Begins, BASports.com Cements Its Legacy as the "GOAT" of Sports Handicapping with Unprecedented Soccer Dominance |
Globe Newswire |
06/11 |
14:26 |
| Athlon Family Office Announces Speakers and Sponsors for Upcoming Elite Family Office Sports Summit June 23–24 |
Globe Newswire |
06/11 |
09:30 |
| Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 |
Globe Newswire |
06/11 |
08:01 |
| Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress |
Globe Newswire |
06/11 |
02:40 |
| Sportradar and Kalshi Announce First-of-its-Kind Data and Infrastructure Global Partnership for Prediction Markets |
Globe Newswire |
06/08 |
08:00 |
| $SRAD Securities Notice: BFA Law Notifies Sportradar Investors of the Filed Securities Class Action to Recover Losses – Act before July 17 Deadline if You Lost Money |
Globe Newswire |
06/08 |
06:17 |
| G-III Apparel Group, LTD. Reports First Quarter Fiscal 2027 Results and Raises Earnings Guidance |
Globe Newswire |
06/05 |
07:00 |
| $SRAD Stock Notification: Lose Money on Your Sportradar Investment? Contact BFA Law about the Ongoing Securities Fraud Class Action |
Globe Newswire |
06/05 |
06:36 |
| Sportradar Nets Official Wimbledon Tennis Data and AV Betting Rights Deal |
Globe Newswire |
06/04 |
04:30 |
| SRAD Legal Claims: Sportradar may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about the Pending Securities Fraud Class Action |
Globe Newswire |
06/03 |
06:07 |
| Legend Biotech Announces Late-Breaking Oral Presentation at EHA 2026 Showcasing Initial Phase 1 In Vivo CAR-T Data with LB2501 in Non-Hodgkin Lymphoma (NHL) |
Globe Newswire |
06/02 |
09:30 |
| A $125 Million Apparel Bet Just Started Paying Out |
Globe Newswire |
06/02 |
08:30 |
| SRAD Class Action Lawsuit: Sportradar 22% Stock Drop Triggers Securities Fraud Class Action on behalf of Harmed Investors – Contact BFA Law by July 17 |
Globe Newswire |
06/01 |
06:07 |
| $SRAD Securities News: Sportradar Accused of Securities Fraud in Filed Class Action Lawsuit – Investors with Losses Notified to Contact BFA Law by July 17 Deadline |
Globe Newswire |
05/29 |
06:33 |
| American Oncology Network Announces Research Studies to be Presented at ASCO 2026 Annual Meeting |
Globe Newswire |
05/28 |
09:00 |
| Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma |
Globe Newswire |
05/28 |
02:00 |
| G-III Apparel Group Declares Quarterly Dividend |
Globe Newswire |
05/27 |
07:00 |
| SRAD Investor Alert: Did Sportradar Mislead Investors about its Revenue Sources? BFA Law Notifies Investors with Losses of the Upcoming July 17 Securities Class Action Deadline |
Globe Newswire |
05/27 |
06:34 |
| InnoCare Announces Approval of Orelabrutinib in Australia |
Globe Newswire |
05/27 |
06:02 |
| $SRAD Shareholder Announcement: Sportradar may have Misled Investors about its Revenue Sources – Contact BFA Law about the Pending Securities Fraud Class Action |
Globe Newswire |
05/25 |
07:07 |
